ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A10AD05 | BioTech | Insulin aspart - 30%, Insulin aspart protamine - 70% | 8085 | 145114/1 | NOVOMIX 30 | 100IU/ml | 5 x 3ml | Injectable suspension | SC | Mersaco | Novo Nordisk Production SAS, Chartres | France | 4,264,012 L.L | 23.08 | B | Novo Nordisk AS | Denmark | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A10AD05 | BioTech | Insulin aspart - 30%, Insulin aspart protamine - 70% | 2016 | 208836/03 | NOVOMIX 30 | 100IU/ml | 5 x 3ml | Injectable suspension | SC | Mersaco | Novo Nordisk AS | Denmark | 4,264,012 L.L | 23.08 | B | 2/5/2024 | 0 | ||
A10AD05 | BioTech | Insulin aspart - 30%, Insulin aspart protamine - 70% | 8111 | 42415/1 | NOVOMIX 30 | 100IU/ml | 5 x 3ml | Injectable suspension | SC | Mersaco | Novo Nordisk Produçao Farmacêutica Do Brazil Ltda | Brazil | 4,264,012 L.L | 23.08 | B | Novo Nordisk AS | Denmark | 2/5/2024 | 0 |